NICOLE BONILLA JIMENEZ: Open Payments
NPI 1790444081 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,224 in 119 payments from 18 companies in 2025. Trend: 2023 $1,872 · 2024 $2,053 · 2025 $2,224
Food & beverage: $2,224
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $312 |
| AstraZeneca Pharmaceuticals LP | 10 | $286 |
| GlaxoSmithKline, LLC. | 24 | $247 |
| Verona Pharma, Inc. | 14 | $236 |
| GENZYME CORPORATION | 7 | $203 |
| Electromed, Inc. | 11 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $163 |
| Amgen Inc. | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Viatris Specialty LLC | 4 | $78 |
Products named: DUPIXENT, Ohtuvayre, BREZTRI, SMARTVEST, TRELEGY ELLIPTA, OFEV, NUCALA, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
